MARKETS / NYSE / EHC

NYSE · SERVICES-HOSPITALS · LARGE CAP

Encompass Health Corp. EHC

18 fiscal years on record · USD · FY2025 reported · SEC filings only

Revenue

$5.9B

▲ 10.5% YoY

Net income

$566.2M

▲ 24.2% YoY

Free cash flow

$439.2M

▲ 21.9% YoY

In brief

What this company does

The company provides specialized rehabilitative treatment, using advanced technology and intensive therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence and quality of life. It operates hospitals in 39 states and Puerto Rico, with concentrations in Florida and Texas. As of December 31, 2025, it operated 173 inpatient rehabilitation hospitals. As of December 31, 2025, the company employed over 42,000 individuals. Substantially all of the patients it serves, or 92%, are admitted from acute-care hospitals following physician referrals for specific acute inpatient rehabilitative care.

Written from the business description in Encompass Health Corporation's annual report to the U.S. Securities and Exchange Commission, filed 26 February 2026. Every sentence was checked against that document before publication.

Growth

USD 5.9B

Revenue, FY2025 · full 18-year series below

Revenue $B Net income $B

FY2025 · Revenue 5.9 · Net income 0.6

Compound annual growth

Revenue

+10.9%

+10.7%

+6.5%

+8.0%

Net income

+27.8%

+14.8%

+12.0%

−3.0%

EPS, diluted

+27.1%

+14.2%

+11.2%

−2.6%

Dividend / share

−5.8%

−8.5%

−2.0%

Returned to shareholders

+32.3%

+14.2%

+6.5%

3 yrs

5 yrs

10 yrs

15 yrs

Revenue compounded at +10.7% a year over five years — but profit grew faster: net income at +14.8%, earnings per share at +14.2%.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

13 cents

of every revenue dollar became profit

Operating margin Net margin

FY2025 · Operating 16.1% · Net 12.8%

ROE

FY2025 · ROE 25.1%

Gross margin—

Operating margin16.1%

Net margin12.8%

Return on assets11.1%

EBITDAUSD 1.3B

Each USD of equity produced 25 cents of profit this year.

Cash & shareholders

USD 229.1M

returned in FY2025 · dividends + net buybacks

Free cash flow $M

FY2025 · FCF 439.2

Net buybacks $M Dividends $M

FY2025 · Dividends 71.1 · Net buybacks 158.0

Dividends paidUSD 71.1M

Net buybacksUSD 158.0M

Share of profit40.5%

Consecutive raises2 years

USD 71.1M in dividends and USD 158.0M in buybacks — 40% of the year's profit went back to shareholders.

Total assetsUSD 7.1B

EquityUSD 2.4B

CashUSD 72.2M

Gross debtUSD 2.4B

Net debtUSD 2.4B

Current ratio1.08×

Net debt stands at 97% of equity.

The 18-year record

18 fiscal years

Every figure from documents filed with the SEC · USD

row low → row highnegative

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Revenue $B	5.9	5.4	4.8	4.3	4.0	3.6	4.6	4.3	3.9	3.6	3.2	2.4	2.3	2.2	2.0	1.9	1.8	1.8
Operating income $B	1.0	0.7	0.6	0.5	0.5	0.4	0.6	0.5	0.5	0.5	0.4	0.4	0.4	0.3	0.2	0.2	0.1	·
EBITDA $B	1.3	1.0	0.9	0.7	0.7	0.6	0.8	0.7	0.7	0.7	0.5	0.5	0.5	0.4	0.3	0.3	0.2	·
Income tax $B	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	−0.7	−0.0	−0.1
Net income $B	0.6	0.5	0.4	0.3	0.4	0.3	0.4	0.3	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.9	0.1	0.3
Free cash flow $B	0.4	0.4	0.3	0.1	0.2	0.3	0.3	0.5	0.4	0.5	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.2
EPS, diluted $	5.54	4.46	3.47	2.70	4.11	2.85	3.61	2.93	2.84	2.59	1.91	2.29	2.58	1.67	1.91	8.28	0.77	2.62
Dividend / sh $	0.72	0.64	0.60	0.86	1.12	1.12	1.10	1.04	0.98	0.94	0.88	0.78	0.36	0.00	0.00	·	·	·
Payout %	13	14	17	37	27	39	30	34	34	34	42	30	5	0	0	·	·	·
ROE %	25.1	24.5	23.8	16.8	23.6	19.3	27.3	24.1	28.7	36.8	33.8	54.3	101.8	90.7	1312.6	·	·	·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance

Company facts, as filed

How we verify · 0 failures in 70 reconciliationsAUDITED

Reconciled in 18 of 19 fiscal years. 6 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures

ActivityServices-Hospitals

Listed onNYSE

Incorporated inDelaware

Fiscal year endsDecember 31

Data on record since2008